Merck sued the US to block the drug pricing law. Will other pharma companies follow suit?
Merck may be the first company to sue and try to stop the Inflation Reduction Act. But it almost certainly won’t be the only one.
The lawsuit likely aims to stop the US from publishing the first list of drugs that would be subject to pricing negotiation by Medicare, with Merck alleging that the IRA violates the First and Fifth Amendments by forcing the company to give discounts without the option of walking away, according to the suit, which was filed Tuesday in the US District Court for the District of Columbia.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.